Established · publishing since 2000Rising activity
Glioma Diagnosis and TreatmentCancer, Hypoxia, and MetabolismATP Synthase and ATPases ResearchEpigenetics and DNA MethylationChromatin Remodeling and Cancer
Publications
368
Citations
11,158
Est. group size
~101
Recurring co-author estimate
Active years
27
Publishing since 2000
In context
Among 4,953 established Medicine PIs within our index
Citations: 11,158p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 45.0p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~15 · 12% small-team papers (≤3 authors) · across 21 venues
Publication cadence
Publications per year over the last 10 years — averaging 45.0/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Lactylation fuels nucleotide biosynthesis and facilitates deuterium metabolic imaging of tumor proliferation in preclinical models of H3K27M-mutant gliomas
Science Translational Medicine · 2026
- Temporal regulation of human reactive astrocytes reveals their capacity for antigen presentation
Neuron · 2026
- Diagnostic Utility and Clinicopathologic Associations of Histone H3 Lysine 27 Trimethylation (H3K27me3) Immunohistochemistry for Merkel Cell Carcinoma
Modern Pathology · 2025
- TMIC-53. Novel therapy for diffuse midline glioma: Targeting oncohistone drivers with P300/CBP inhibition and Delta-24-RGD
Neuro-Oncology · 2025
- TRLS-07. PNOC016: INTRATUMORAL PHARMACOKINETICS AND PHARMACODYNAMIC (PK/PD) RESULTS FROM A TARGET VALIDATION STUDY OF A NOVEL PAN-HDAC AND PI3K INHIBITOR, FIMEPINOSTAT, IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), RECURRENT MEDULLOBLASTOMA (MB), AND RECURRENT HIGH-GRADE GLIOMA (HGG)
Neuro-Oncology · 2024
- An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma
Cell Reports · 2023
- DIPG-46. TARGETING THE METABOLIC ERK5-PFKFB3 AXIS IN PEDIATRIC DIFFUSE MIDLINE GLIOMA
Neuro-Oncology · 2023
- Figure S2 from Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
2023
- Table S2 from Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
2023
- Table S1 from Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
2023
- Figure S3 from Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
2023
- Figure S1 from Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
2023
- Figure S2 from Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
2023
- Table S2 from Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
2023
- Table S1 from Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
2023
Publishes in
- Neuro-Oncology×55
- Cancer Research×16
- bioRxiv (Cold Spring Harbor Laboratory)×10
- Acta Neuropathologica Communications×6
- Science Translational Medicine×5
Similar researchers
By research-topic overlap
- Matthew Pun
Medicine · University of Michigan
- Ziyun Xia
Medicine · University of Michigan
- Mateus Mota
Medicine · University of Michigan
- Tingting Qin
Medicine · University of Michigan
- Carl Koschmann
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile